IMPDH2 and hepatocellular carcinoma: Furthermore, they found that inosine monophosphate dehydrogenase 2 (IMPDH2) was the critical pharmacological target, since knockdown of IMPDH2 reversed SA-induced ferroptosis in HCC cells.